VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0993669
Sex: U
Age:
State: NY

Vax Date: 01/05/2021
Onset Date: 01/11/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210111; Test Name: Covid 19 test; Test Result: Positive

Allergies:

Symptoms: tested positive after taking the 1stdose/tested positive for Covid/they got a result for asymptomatic employee that tested positive with COVID 19; tested positive after taking the 1stdose/tested positive for Covid/they got a result for asymptomatic employee that tested positive with COVID 19; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect. A contactable Nurse reported similar events for 3 patients.This is 3rd of 3 reports. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 05Jan202 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient tested positive for Covid after taking the 1st dose/got a result for asymptomatic employee that tested positive with covid 19 on 11Jan2021. The nurse reported that got the first shot on the 05Jan2021 for all of the 50 employees and 70 residents. On 11Jan2021, they got a result for asymptomatic 3 employees that tested positive with COVID 19. HCP had questions about 2nd dose guidelines, if they can take the second shot after testing positive. The outcome of the events was unknown. Information about lot/batch number has been requested.; Sender's Comments: Based on temporal association, a possible contributory role of BNT162B2 cannot be excluded for reported events.,Linked Report(s) : US-PFIZER INC-2021049693 same reporter/ drug/ event, different patients.;US-PFIZER INC-2021049694 same reporter/ drug/ event, different patients.

Other Meds:

Current Illness:

ID: 0993670
Sex: F
Age:
State: TN

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: left armpit and left breast lymph node swelling; left armpit and left breast lymph node swelling and still hurting; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the left arm on 15Jan2021 at 09:15 (at the age of 50-years-old) as a single dose for COVID-19 immunization. Medical history included the patient was a diabetic; penicillin, crustacean, rye, wheat and barley allergy; and COVID-19 diagnosed prior to the vaccination. Concomitant medications included metformin, atorvastatin, dapagliflozin propanediol monohydrate (FARXIGA) and an unspecified hormone replacement. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 15Jan2021 at 13:00, the patient experienced left armpit and left breast lymph node swelling, which was still hurting and swelling at the time of this report. The events resulted in a doctor or other healthcare professional visit. The patient was treated with ibuprofen (ADVIL) every 6-8 hours for pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of left armpit and left breast lymph node swelling and still hurting was not resolved at the time of this report. information on the lot/batch number has been requested.

Other Meds: METFORMIN; ATORVASTATIN; FARXIGA

Current Illness:

ID: 0993671
Sex: F
Age:
State:

Vax Date: 01/18/2021
Onset Date: 01/19/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swollen/tender lymph nodes under right arm; Swollen/tender lymph nodes under right arm; Hard for movement; This is a spontaneous report from a non-contactable nurse (patient). A 24-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on the right arm, on 18Jan2021 08:00 at a single dose for COVID-19 immunization. The patient medical history was not reported. Patient was not pregnant at the time of vaccination. There were no other medications received within 2 weeks of vaccination. The patient experienced swollen/tender lymph nodes under right arm and hard for movement on 19Jan2021 08:00. Patient was recovering from the events and no treatment was received. The events were considered non-serious. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0993672
Sex: M
Age:
State: FL

Vax Date: 01/11/2021
Onset Date: 01/14/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Name: lab test; Result Unstructured Data: Test Result:Patient had lab test once in a month and everythin; Comments: Patient had lab test once in a month and everything was okay. No problem.

Allergies:

Symptoms: large blister to front half of scalp; itching to front half of scalp; Started to have small swelling nodes in the scalp; Started to have small swelling nodes in the scalp; This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/lot number: EL1284), via an unspecified route of administration on 11Jan2021 at single dose for COVID-19 immunization. The patient's medical history included allergy to dust, runny nose and blood pressure. The patient's concomitant medications included fexofenadine hydrochloride (ALLEGRA) for allergy to dust and runny nose, patient also took some medicines to control blood pressure. It was reported that the patient experienced large blister and itching to front half of scalp. The clinical course was as follows. He took the vaccine on last Monday 11Jan2021, and three days later (14Jan2021) that blisters appeared in his scalp. He noticed when he woke up the morning on his front half was a large blister and itching. He wanted to know if it is a reaction and what should he do. The physician looked at him and gave prednisone to take for 5 days. Blisters were gone. Three days after the vaccine (14Jan2021), patient started to have small swelling nodes in the scalp. Patient had about two or three nodes in his scalp. Patient didn't have a fever. Due date of second shot was 01Feb2021. Patient had lab test once in a month and everything was okay. No problem. For treatment in response to event small swelling nodes in the scalp: patient stated no, he was taking fexofenadine hydrochloride. Patient just took it by himself it was an anti-allergic. Patient normally take if he has allergy to dust or a runny nose. The outcome of blisters to front half of scalp was recovered in Jan2021, and for other events was unknown. No investigation assessment. Information on the lot/batch number has been requested. Follow-up (17Jan2021): New information reported from a contactable consumer (patient) includes: patient details, medical history, concomitant medications, lab data, new events (add small swelling nodes in the scalp).

Other Meds: ALLEGRA

Current Illness:

ID: 0993673
Sex: F
Age:
State: TX

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Backache and back spasms; Backache and back spasms; Ear pain on right side of head; I have Trigeminal Neuralgia and it made my face temporarily flare up with the side face pain; I have Trigeminal Neuralgia and it made my face temporarily flare up with the side face pain; This is a spontaneous report from a contactable Other Health Professional reporting for herself A 43 years old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on 18Jan2021 at 12:15 at single dose intramuscular on arm left for COVID-19 immunization. Medical history included Trigeminal Neuralgia, asthma, High blood pressure, CSF leak out of my nose (which has spontaneously healed), Seasonal allergies, milk allergies to lactose, Allergy to arthropod sting (tongue swelled up once from a hornet sting on hand) and allergic reaction to antibiotics (hands swell up). Concomitant medications included propranolol. On 18Jan2021 soon after vaccination (reported as 18Jan2021 at 12:15), patient experienced backache and back spasms. Ear pain on right side of head. Patient had trigeminal Neuralgia and it made her face temporarily flare up with the side face pain (as reported). Patient didn't received treatment. At the time of the reporting the patient was recovering from the events. information on the lot/batch number has been requested.

Other Meds: PROPRANOLOL

Current Illness:

ID: 0993674
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: her hand was slightly swollen and today it is even more swollen; This is a spontaneous report from a consumer (patients husband). A 50-year-old female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number), via an unspecified route of administration, on an unspecified date as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included the flu shot on August 29th. The consumer reported that his wife took the second dose of the vaccine on "Monday" morning. Yesterday she noticed that her hand was slightly swollen and today it is even more swollen. The event was non-serious. The clinical outcome of the event swelling of hands was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 0993675
Sex: F
Age:
State: NY

Vax Date: 01/05/2021
Onset Date: 01/08/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210108; Test Name: tested positive after receiving the Covid-19 vaccine; Test Result: Positive ; Comments: asymptomatic

Allergies:

Symptoms: tested positive after receiving the Covid-19 vaccine; tested positive after receiving the Covid-19 vaccine; This is a spontaneous report from a Pfizer-sponsored program from a contactable nurse. This case refers to the first of three employees tested positive for Covid-19 after receiving the vaccine. A 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EL0140, expiry date Mar2021), via an unspecified route of administration, on 05Jan2021 at single dose for COVID-19 immunisation. Age at vaccination was 51-years-old. Medical history and concomitant medications were unknown. The patient was tested on 08Jan2021. She received the results on 12Jan2021 and tested positive after receiving the Covid-19 vaccine. She is asymptomatic. It hasn't affected her but she has not been able to work. The event was reported serious as medically significant. Outcome was unknown. She states she was asking about getting 2nd vaccine.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported tested positive based on the known safety profile. However the short duration of 3 days since the vaccine first dose is given it is unlikely patient would have fully developed immunity.

Other Meds:

Current Illness:

ID: 0993676
Sex: F
Age:
State: IL

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I felt weak; hard to focus; fatigued; This is a spontaneous report from a contactable healthcare professional (the patient). A 52-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscular in the left arm on 19Jan2021 at 12:45 (at the age of 52-years-old) as a single dose for Covid-19 immunization. Medical history was reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not have any known allergies. The patient's concomitant medications included omeprazole (MANUFACTURER UNKNOWN) for unknown indications from unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On 19Jan2021 at 13:30, the patient experienced felt weak, hard to focus, and fatigued. It was reported that the shot was at 12:45 pm, the patient had to lay down until she went to bed. Felt 80% better in the morning. The patient did not receive any treatment for the events. The clinical outcome of the events asthenia, disturbance in attention and fatigue was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds: OMEPRAZOLE

Current Illness:

ID: 0993677
Sex: F
Age:
State: CA

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: nauseous; mild to moderate arm pain; injection site pain; Pain was from wrist to shoulder; moderate vasomotor symptoms; body aches; This is a spontaneous report from contactable nurse (patient herself). A 48-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 10:00 in right deltoid at single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included estrogens conjugated, medroxyprogesterone acetate (PREMPRO). On 19Jan2021, patient experienced mild to moderate arm pain in arm that had shot, more than just injection site pain. Pain was from wrist to shoulder. 2-3 hours later moderate vasomotor symptoms followed with body aches. She took celecoxib (CELEBREX)and paracetamol (TYLENOL), body aches got better. 7 hours post injection, she felt nauseous and took ondansetron (ZOFRAN). Outcome of events were unknown. Information on the lot/batch number has been requested.

Other Meds: PREMPRO

Current Illness:

ID: 0993678
Sex: F
Age:
State: DE

Vax Date: 12/31/2020
Onset Date: 01/05/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210107; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Diagnosed with Bell's Palsy from Covid-19 injection (1st dose.)/left sided face droop; Stroke; Lower left pain under ear, sudden onset; This is a spontaneous report from two contactable consumers. A 50-year-old female patient (not pregnant) received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 31Dec2020 08:30 at single dose for COVID-19 immunisation. Medical history included depression, anxiety, Post-traumatic stress disorder (PTSD), elevated pressure increased (BP), elevated cholesterol, spondylosis with radiculopathy. Known allergies: NSAID's and augmentin. Concomitant medications included hydrochlorothiazide, venlafaxine hydrochloride (EFFEXOR), hydroxyzine, atorvastatin and ascorbic acid;betacarotene;biotin; calcium; chloride; chromium; copper; folic acid; iodine; iron; magnesium; manganese; molybdenum; nickel; nicotinic acid; pantothenic acid; phosphorus; potassium; pyridoxine hydrochloride; riboflavin; selenium; silicon; thiamine; vanadium; vitamin B12 NOS; vitamin D NOS; vitamin E NOS; vitamin K NOS; xantofyl; zinc (CENTRUM SILVER WOMEN 50+). On 05Jan2021 at 13:00, patient experienced lower left pain under ear, sudden onset. Then, noticed symptoms of a stroke. Left sided face droop. Patient went to ER (emergency room). Patient was diagnosed with Bell's Palsy from Covid-19 injection (1st dose). Patient received treatments for the events included prednisone, acyclovir, ointment to protect eye and eye patch for covering of left eye. Lab test included Nasal Swab: negative on 07Jan2021. Outcome of the events was resolving. Information on Lot/Batch number has been requested.

Other Meds: HYDROCHLOROTHIAZIDE; EFFEXOR; HYDROXYZINE; ATORVASTATIN; CENTRUM SILVER WOMEN 50+

Current Illness:

ID: 0993679
Sex: M
Age:
State: IL

Vax Date: 01/08/2021
Onset Date: 01/18/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210118; Test Name: COVID-19 Antibody test; Test Result: Negative

Allergies:

Symptoms: antibody test done 18Jan2021 and the results were negative; This is a spontaneous report from a contactable nurse. A male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on 08Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of BNT162B2 for COVID-19 immunization on 18Dec2020. Patient received the second dose of the Pfizer vaccine on 08Jan2021 and had an antibody test performed on 18Jan2021. The results were AB IGG negative response. Patient asked "Have you encountered this in your trials? Is there a point of contact that I could talk to about my immune response? I take no medications, have no significant medical history. I think it would be important information for me and my patients to know if some people just don't make antibodies to COVID-19." The outcome of the event antibody test/negative was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 0993680
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: hallucinating; hands are very swollen; fever; she was also 'really swollen' not just on the injection site but on her hands and face.; she was also 'really swollen' not just on the injection site but on her hands and face.; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EL8982), via an unspecified route of administration on an unspecified date single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced hallucinating, hands are very swollen, fever, she was also 'really swollen' not just on the injection site but on her hands and face, all on an unknown date. The events outcome was unknown.

Other Meds:

Current Illness:

ID: 0993681
Sex: F
Age:
State: MI

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20201005; Test Name: Nasal Swab; Test Result: Negative ; Test Date: 20201108; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Soreness in L arm; soreness in L axilla; Soreness in LU torso; Numbness/tingling in lips and tongue; Metal taste; Numbness/tingling in lips and tongue; This is a spontaneous report from a contactable nurse (patient). A 50-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK9231 and expiry date: unknown), via an unspecified route of administration on the left arm, on 29Dec2020 08:00 at a single dose for COVID-19 immunization. Medical history included hyperlipidemia, chicken allergy. Patient was not pregnant at the time of vaccination. Patient previously took BACTRIM and experienced allergy. There were no other medications received within 2 weeks of vaccination. The patient soreness in L arm, L trap, L axilla, LU torso, numbness/tingling in lips and tongue and metal taste on 29Dec2020 09:00. Outcome of the events was recovered. Treatment was not received for the events. The patient underwent lab tests and procedures which included nasal swab/ covid test: negative on 05Oct2020 and negative on 08Nov2020. Patient was not diagnosed with COVID-19 prior to vaccination and has been tested post-vaccination. The events were considered non-serious.

Other Meds:

Current Illness:

ID: 0993682
Sex: M
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pain in the injection site; Soreness in lower part of his leg; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a 75-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took acetylsalicylic acid (ASPIRIN) 36 hours before the 1st shot of vaccine. Patient called in because he took acetylsalicylic acid 36 hours before the 1st shot of vaccine. Asking how much it will effect the efficacy. Mentioned he felt a little bit of pain in the injection site and soreness in lower part of his leg an unspecified date. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0993683
Sex: F
Age:
State: MI

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills; fever; Injection site pain; muscle aches; vomiting; nausea; This is a spontaneous report from a non-contactable consumer (patient). A 24-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EK9231, expiration date not reported), via an unspecified route of administration, on the left arm, on 15Jan2021 at 11:00, at a single dose for Covid-19 immunization. Medical history included allergies to penicillin. The patient did not receive other vaccines in four weeks. The patient is not pregnant. Concomitant medications included metformin, omeprazole, melatonin, iron and ethinylestradiol, levonorgestrel (SRONYX). The patient previously took first dose of bnt162b2 (lot number EH9899) on 28Dec2020 at 11:15 AM, on the left arm, at a single dose for Covid-19 immunization, cephalosporin and Imitrex and experienced allergies. On 16Jan2021 at 01:00, the patient experienced chills, injection site pain, fever, muscle aches, and nausea/vomiting. No treatment was given for the adverse events. The patient has no Covid prior to vaccination and not Covid tested post vaccination. The patient recovered from the events in Jan2021. No follow-up attempts are possible. No further information is expected.

Other Meds: METFORMIN; OMEPRAZOLE; MELATONIN; IRON; SRONYX

Current Illness:

ID: 0993684
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: trouble breathing; This is a spontaneous report from a non-contactable consumer from a Pfizer-sponsored program. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient stated, "I need to ask about, I need to ask about shortness of breath, I'm having a hard time breathing. I had the vaccine last night and having trouble breathing" on an unspecified date. The outcome of the event was unknown. No follow up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0993685
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Name: covid test; Result Unstructured Data: Test Result:Positive

Allergies:

Symptoms: covid test which came back positive; covid test which came back positive; This is a spontaneous report from a Pfizer-sponsored program . A contactable female consumer (patient) of unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date unknown), via an unspecified route of administration on unspecified date at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient stated that she received the vaccine and then took Covid test which came back positive (unknown date). The patient would like to know if it is safe for her to get second dose. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0993687
Sex: U
Age:
State: KS

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: red raised rash over body; fever; fatigue; diarrhea; intestinal stomach pain; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer, the patient. A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) solution for injection on 12Jan2021 (at an unknown age) as a single dose for COVID-19 vaccination. The patient received BNT162B2 dose number 1 in Dec2020. Medical history and concomitant medications were not reported. On 12Jan2021, the patient experienced fever, fatigue, diarrhea and intestinal stomach pain. On 18Jan2021, the patient experienced red raised rash over body. The outcome of the events fever, fatigue, diarrhea, intestinal stomach pain and red raised rash over body was not recovered. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 0993688
Sex: U
Age:
State: CA

Vax Date: 12/23/2020
Onset Date: 12/01/2020
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210105; Test Name: test for COVID; Test Result: Positive ; Test Date: 20210114; Test Name: test for COVID; Test Result: Negative

Allergies:

Symptoms: tested positive for COVID; tested positive for COVID; back pain; heavy cold symptoms; fatigue; Experienced a sore arm for 24 hours; This is a spontaneous report from a contactable Nurse (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received her vaccine in the left arm deltoid on 23Dec2020. The patient experienced a sore arm for 24 hours in Dec2021. On 31Dec2020, she experienced back pain, heavy cold symptoms and fatigue. On 05Jan2021, the patient was tested positive for COVID. On 09Jan2021 she lost taste and smell. On 14Jan2021, she tested negative for COVID. As of today, 19Jan2021, she has not been able to go back to work. Event took place after use of product. The outcome of event sore arm was recovered on an unspecified date. The outcome of event COVID-19 was recovered on 14Jan2021. The outcome of the other events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, individuals may not be protected until at least 7 days after their second dose of the vaccine. It is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.

Other Meds:

Current Illness:

ID: 0993689
Sex: M
Age:
State: MI

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: soreness on his arm/He said his left arm was barely sore after receiving the COVID-19 Vaccine; This is a spontaneous report from a contactable consumer reporting for himself. A 23-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EL1283/expiration date: Apr2021), via an unspecified route of administration, on 18Jan2021 16:00 (at the age of 23 years old) as a single dose in the left arm for COVID-19 IMMUNIZATION. Relevant medical history and concomitant medication were reported as none. Past vaccine history included the patient received a flu vaccine injection on Oct2020 and he could barely lift his arm up after receiving a flu vaccine injection and on Nov2020 approximately 5 weeks ago, the patient received PPSV23 vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Jan2021, the patient experienced soreness on his arm, started slowly, about 2 hours post COVID-19 vaccination. He said his left arm was barely sore after receiving the COVID-19 Vaccine. The soreness went away completely on 19Jan2021. The patient did not receive any treatment for the event. The outcome of the event soreness on his arm was recovered on 19Jan2021.

Other Meds:

Current Illness:

ID: 0993690
Sex: F
Age:
State:

Vax Date: 12/29/2020
Onset Date: 12/30/2020
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: arm pain; chills; low grade fever; myalgia; Raynaud's Syndrome (vasoconstriction of the fingers); This is a spontaneous report from a contactable other health professional. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number, via an unspecified route of administration on 29Dec2020 as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 30Dec2020, the day after receiving the first dose of the vaccine, the patient experienced arm pain, chills, low grade fever, myalgia, Raynaud's syndrome, then they resolved completely. Events are non-serious. The clinical outcome of the events arm pain, chills, low grade fever, myalgia, Raynaud's syndrome was recovered. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 0993691
Sex: M
Age:
State: NM

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Tingling in arm after injection; This is a spontaneous report from a contactable pharmacist. A 26-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL1284), intramuscular in left arm, on 29Dec2020 at 13:00 (01:00 PM), at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took sulfadiazine and experienced allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in a hospital facility. On 29Dec2020 at 01:01 PM (1 minute after injection), the patient experienced tingling in arm after injection. The rapid response was observed for 30 minutes. No other intervention was done; no treatment was received for the event. The event was considered non-serious. Since the vaccination, the patient has not been tested for COVID-19. The patient recovered from the event on an unspecified date.

Other Meds:

Current Illness:

ID: 0993692
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Name: Covid; Result Unstructured Data: Test Result:Positive

Allergies:

Symptoms: tested positive for Covid; tested positive for Covid; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reporting for self that a female patient of an unspecified age received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Caller is due for a second dose of covid vaccine tomorrow. She has tested positive for covid before second dose. Outcome of events was unknown. Information on Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0993693
Sex: F
Age:
State: CA

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache which she described as more of starting on her neck going up to her head/ She feels a little bit of a headache, more neck than head; Headache which she described as more of starting on her neck going up to her head/ She feels a little bit of a headache, more neck than head; This is a spontaneous report from a contactable consumer, the patient. A 84 years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: Unknown) on Jan2021 as a single dose, for COVID-19 vaccination. The patient medical history and concomitant medications were not reported. On Jan2021,the patient experienced headache which she described as more of starting on her neck going up to her head/ she feels a little bit of a headache, more neck than head. Patient stated this is normal for her, she often gets headaches. Consumer commented that she thinks it is not necessary for her to call her HCP about it when it is something that she can take care of herself. 'Wants to know if taking either Tylenol or Advil would interact with the vaccine and did mention that she has taken the medications yesterday (unclear if patient had taken medications before or after receiving vaccine). The consumer (patient) unwilling to complete the report. The clinical outcome of headache and neck pain was unknown. Information about Lot number has been requested.

Other Meds:

Current Illness:

ID: 0993694
Sex: F
Age:
State: TX

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Poor sleep; Nausea; Fever; Fatigue; headache; pain/soreness all over; itch at injection site; Pain at injection site; redness at injection site; Lump at injection site; warm skin at injection site; This is a spontaneous report from a contactable healthcare professional (the patient). A 34-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number EJ1686), via an unspecified route of administration in the right arm on 19Jan2021 at 09:30 AM (at the age of 34-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history included HTN (hypertension), depression, ADHD (attention deficit hyperactivity disorder), vitamin D deficiency. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included atenolol, clonazepam, escitalopram oxalate (LEXAPRO), pantoprazole, lisdexamfetamine mesilate (VYVANSE), all for unknown indications from unknown dates and unknown if ongoing. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number EL0140), via an unspecified route of administration on 29Dec2020 at 09:00 AM (at the age of 34-years-old), in the right arm as a single dose for COVID-19 immunization. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took and had allergies to atomoxetine hydrochloride (STRATTERA). On 20Jan2021 at 12 AM, the patient experienced poor sleep, nausea, fever, fatigue, headache, pain/soreness all over, itch at injection site, pain at injection site, redness at injection site, lump at injection site, warm skin at injection site. The patient did not receive any treatment for the events. The clinical outcome of poor sleep, nausea, fever, fatigue, headache, pain/soreness all over, itch at injection site, pain at injection site, redness at injection site, lump at injection site, and warm skin at injection site was recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: ATENOLOL; CLONAZEPAM; LEXAPRO; PANTOPRAZOLE; VYVANSE

Current Illness:

ID: 0993695
Sex: F
Age:
State: NY

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 02/02/2021
Hospital: Y

Lab Data: Test Name: CT scan; Result Unstructured Data: Test Result:stroke in the area of the brain that affect speech; Test Name: echocardiogram; Result Unstructured Data: Test Result:Unknown results; Test Name: MRI; Result Unstructured Data: Test Result:stroke in the area of the brain that affect speech; Test Name: Vitals; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptoms: Couldn't speak, slurring words, stuttering, couldn't formulate a sentence; stroke; This is a spontaneous report from a contactable consumer. A 97-year-old female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 16Jan2021 14:15 at single dose for covid-19 immunization. Medical history included ongoing atrial fibrillation(A-flib), took medication for that. Concomitant medication included acetylsalicylic acid (BABY ASPIRIN), rosuvastatin calcium (CRESTOR). Additional vaccines administered on same date of pfizer suspect reported as no. Prior vaccinations within 4 weeks, AES follow prior vaccinations and family medical history all reported as no. The patient got her first dose on 16Jan2021 and that evening she began to have a stroke. The patient was on blood thinners (apixaban(ELIQUIS) and questor). Event reported as "Couldn't speak, slurring words, stuttering, couldn't formulate a sentence" with onset date 16Jan2021. Event was serious as hospitalization from 17Jan2021 to 18Jan2021. The outcome of the events was not recovered/not resolved. Patient was caller's mother. Four hours later, patient couldn't speak and was slurring words. Ambulance was called, vitals were checked, and patient was told she was ok. Next morning patient was the same. Ambulance was called again and patient had a stroke. Caller stated the stroke was very coincidental. Patient had the COVID-19 Vaccine at about 2PM. Patient had A-fib. Stroke affected patient's speech, but not terribly. Patient was on a blood thinner at the time of the report because of MRI and CT scan results. The patient was taking acetylsalicylic acid (BABY ASPIRIN), but that was taken away at time of the report. The patient was on rosuvastatin calcium (CRESTOR) 0.5 at time of the report. Next appointment for second COVID-19 Vaccine was 06Feb2021. Caller was concerned. Patient never had a stroke before. The reporter wanted to know if this had been previously reported. Saturday night was when patient's speech began slurring. The patient had the Pfizer COVID-19 Vaccine that afternoon. EMS didn't take patient to the hospital on Saturday night, just took vitals and left. Patient's speech was going in and out. Caller reached out to patient Sunday morning and patient was having the same speech issues. Patient was stuttering and couldn't formulate a sentence. Ambulance was called and patient was transported to (health center). CT scan and MRI showed patient had a stroke in the area of the brain that affect speech. Patient had an echocardiogram. Clarified patient's speech symptoms began on Saturday, 16Jan2021. ? Information of lot/batch number has been requested.

Other Meds: BABY ASPIRIN; CRESTOR

Current Illness: AFib (Patient Medical comments: Verbatim: A-fib takes medication for that)

ID: 0993696
Sex: F
Age:
State: PA

Vax Date: 12/28/2020
Onset Date: 01/04/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210102; Test Name: Covid; Test Result: Negative ; Test Date: 20210104; Test Name: Covid; Test Result: Positive

Allergies:

Symptoms: had COVID symptoms and tested positive for Covid; had COVID symptoms and tested positive for Covid; This is a spontaneous report from a contactable consumer (patient) via a Pfizer Sponsored Program COVAX US Support. A 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EK5730, expiry date not provided) on 28Dec2020 17:30 at single dose in the left arm via an unspecified route of administration for COVID-19 immunisation . There were no relevant medical history and no concomitant medications. The patient took the first dose of the vaccine on 28Dec2020 and by the end of that week she had COVID symptoms. She got tested on that Saturday (02Jan2021) and it was negative, so she went to an urgent care to get tested again on 04Jan2021 and she was positive. She was not visit physician office or emergency room. She was out of quarantine on 14Jan2021, and was due to go get her second dose of the vaccine on 18Jan2021. She was calling to make sure if it's okay to get it. The outcome was unknown.; Sender's Comments: Based on the mechanism of action of BNT162B2 vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the number of days passed since the vaccine was given (7 days in this case). However, a causal relationship between event "had COVID symptoms and tested positive for Covid" (coded to Drug ineffective / COVID-19) and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) cannot be completely excluded.

Other Meds:

Current Illness:

ID: 0993697
Sex: M
Age:
State: IN

Vax Date: 01/15/2021
Onset Date: 01/01/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: his wrist started hurting; This is a spontaneous report from a contactable consumer (patient). An elderly male patient of unspecified age (he is turning 93) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 15Jan2021 at single dose for COVID-19 immunization. Medical history and concomitant medication were not reported. Patient called earlier this morning about the Covid-19 vaccine and reported that he got inoculated on Friday 15Jan2021 and everything went fine. He said that all of a sudden today, his wrist started hurting. He said that he thought it was from the vaccine, but kept doing things around the house and said that it was cracked or dislocated or something, and has nothing to do with the vaccine itself. He said that he is going to see someone about it. He wanted to let Pfizer know this. When asked for his email the patient said that he is turning 93 and has forgotten a lot more than he can remember and began laughing. Outcome of the event was unknown. Information on the lot/batch number has been requested.; Sender's Comments: The reported event his wrist started hurting is likely an intercurrent condition considering the patient's age ( elderly) and not related to BNT162B2 .

Other Meds:

Current Illness:

ID: 0993698
Sex: F
Age:
State:

Vax Date:
Onset Date: 01/18/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Ear was hurting; throat hurting too.; This is a spontaneous report from a Pfizer-sponsored program via a non-contactable consumer reported for herself. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. Medical history included she was a little hoarse and acid reflux problems for the past year. The patient's concomitant medications were not reported. Called before having her first vaccine and had another question. Caller was a little hoarse. Had acid reflux problems for the past year, but she woke up this morning (on 18Jan2021) and her ear was hurting and throat hurting too. Inquiring if she could take the vaccine with those symptoms. Caller indicated that this is not related to the vaccine. It was reported that she was hoarse today (on 18Jan2021), plus her ear and throat were both hurting as well. The outcome of the events was unknown. No follow-up attempts are possible; information about batch number cannot be obtained.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events due to temporal relationship. There is limited information provided in this report. This case will be reassessed once additional information is available.

Other Meds:

Current Illness:

ID: 0993699
Sex: F
Age:
State: CO

Vax Date: 01/10/2021
Onset Date: 01/10/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: had chills; body aches; This is a spontaneous report from a contactable consumer. A 38-years-old female patient received the second dose of BNT162B2 Pfizer-BioNTech COVID-19 Vaccine, via an unspecified route of administration on 10Jan2021 at 09:00 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 10Jan2021 at 21:00 the patient had chills and body aches and had to call off work on the following day. The patient felt 100% fine when she woke up on 12Jan2021. The reported events resolved on 12Jan2021 without any treatment. No follow-up attempts are possible; Information about batch/lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 0993700
Sex: F
Age:
State:

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: dizziness/lightheadedness; the room was spinning; arm soreness; This is a spontaneous report from a contactable consumer (patient). A 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 16Jan2021 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 16Jan2021 the patient experienced arm soreness and on 17Jan2021 developed dizziness, lightheadedness, and the room was spinning. The patient wanted to know if she can take Tylenol. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0993701
Sex: F
Age:
State: OH

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore throat; Headache; fatigue; muscle aches; This is a spontaneous report from a contactable nurse. A 61-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# ELO142), via an unspecified route of administration on 09Jan2021 09:45 single dose for covid-19 immunisation. Vaccine location was right arm. No other vaccine was received in four weeks. Medical history included seasonal allergy. Historical vaccine included BNT162B2 first dose at unknown date. Concomitant medication included ergocalciferol (VIT D) and multivitamin. The patient experienced sore throat on 10Jan2021 02:00, headache on 10Jan2021 02:00, fatigue on 10Jan2021 02:00, muscle aches on 10Jan2021 02:00. Patient was treated with ibuprofen and tylenol. The events outcome was recovered in Jan2021

Other Meds: VIT D

Current Illness:

ID: 0993702
Sex: F
Age:
State: CA

Vax Date: 01/18/2021
Onset Date: 01/19/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Muscle aches; joint aches; exhausted feeling; slight headache; This is a spontaneous report from a non-contactable consumer (patient herself). A 70-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot/batch number and expiration date were unknown), via an unspecified route of administration on the right arm on 18Jan2021 at 12:00 PM at a single dose for COVID-19 immunization, given by the retirement home and administered at the nursing home/senior living facility. Relevant medical history included pre-diabetic, obesity, high lipids, and allergies to some psychiatric (psych) medications (meds) only. Concomitant medications included risperidone, calcium levomefolate (DEPLIN), travoprost (TRAVATAN), ibuprofen, and famotidine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Jan2021 at 15:30 (also reported as "beginning around 3 pm"), the patient experienced muscle aches, joint aches, exhausted feeling, and slight headache mainly in the afternoon. The reporter assessed all the events as non-serious. The patient did not receive any treatment for the events. The patient was recovering from all the events. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: RISPERIDONE; DEPLIN; TRAVATAN; IBUPROFEN; FAMOTIDINE

Current Illness:

ID: 0993703
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fatigue; Muscle aches; Fever; This is a spontaneous report from a contactable consumer, reporting on behalf of their co-worker. This female patient of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (Lot number: UNKNOWN), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 vaccination. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. On an unspecified date, the patient experienced fatigue, muscle aches and fever. It was unknown if treatment was received. The clinical outcomes of the events fatigue, muscle aches and fever were unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0993704
Sex: F
Age:
State: LA

Vax Date: 01/07/2021
Onset Date: 01/17/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210119; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: papular rash with petechiae; papular rash with petechiae; itching; This is a spontaneous report from a contactable other hcp. A 38-years-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# unknown), first dose, intramuscular on 07Jan2021 single dose for covid-19 immunisation. Vaccine location was left arm. Medical history included drug hypersensitivity to pertussis vaccine, erytrhromycin, sulfacetamide. Concomitant medications included celecoxib (CELEXA), ethinylestradiol, norethisterone acetate (MICROGESTIN). The patient experienced papular rash with petechiae on 17Jan2021, itching on 17Jan2021. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 19Jan2021. The events outcome was unknown Information on the Batch/Lot number has been requested.

Other Meds: CELEXA [CELECOXIB]; MICROGESTIN

Current Illness:

ID: 0993705
Sex: F
Age:
State: CA

Vax Date: 12/20/2020
Onset Date: 12/01/2020
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: The patient experienced itching after the first dose of the COVID-19 vaccine.; This is a spontaneous report from a contactable pharmacist. A 26-year-old female patient (not pregnant) received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL0140), intramuscularly on 20Dec2020 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced itching after the first dose of the covid-19 vaccine in Dec2020 with outcome of unknown.

Other Meds:

Current Illness:

ID: 0993706
Sex: U
Age:
State: FL

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: feeling short of breath; This is a spontaneous report from a contactable consumer (patient). A 79-year-old patient of an unspecified gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EL8982, expiration date was unknown), via an unspecified route of administration on the right arm on 20Jan2021 at 11:30 AM at a single dose for COVID-19 immunization administered at the public health department. Relevant medical history included high blood pressure, which was under control with medications (meds). The patient had no allergies to medications, food, or other products. Concomitant medications included hydralazine, carvedilol, rosuvastatin, alendronate sodium (ALENDRONAT), and unspecified meds for high blood pressure. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Jan2021 at 12:00 PM, the patient experienced feeling short of breath for a few minutes soon after leaving the vaccine site. It passed and then happened again a few hours later, but it passed after inhaling some warm mist. The patient assessed the event as non-serious. Therapeutic measures were taken as a result of feeling short of breath, which included inhaling some warm mist. The patient recovered from the event on an unspecified date in Jan2021.

Other Meds: HYDRALAZINE; CARVEDILOL; ROSUVASTATIN; ALENDRONAT

Current Illness:

ID: 0993707
Sex: F
Age:
State: FL

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Skin rash/redness at injection site and in axilla on side of injection; Skin rash/redness at injection site and in axilla on side of injection; Skin rash/redness at injection site and in axilla on side of injection; This is a spontaneous report from a contactable other healthcare professional reported for a female patient. A 28-year-old female patient receive second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL1284; expiration date not provided), intramuscular (anatomical location: arm left) on 19Jan2021 at 13:00 at SINGLE DOSE for covid-19 immunization. Patient's medical history included birth control. Concomitant medications included ethinylestradiol, ferrous bisglycinate, levonorgestrel (BALCOLTRA) as birth control, cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), fluticasone nasal spray, and probiotics. The patient previously took first dose of bnt162b2 (lot number: EH9899; expiration date not reported), intramuscular (anatomical location: left arm) on 29Dec2020 at 09:30 am for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior vaccination. It was also reported that since the vaccination, the patient has not been tested for COVID-19. The patient has no allergies to medications, food, or other products. Facility where the most recent COVID-19 vaccine was administered was reported as workplace clinic. It was also reported that patient was not pregnant at the time of vaccination. On 20Jan2021 at 07:00, the patient experienced skin rash/redness at injection site and in axilla on side of injection. It was reported that no treatment was provided for the events. The events were assessed as non-serious. Outcome of the events was recovering.

Other Meds: BALCOLTRA; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; FLUTICASONE

Current Illness:

ID: 0993708
Sex: M
Age:
State: CA

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pain on arm of injection; fatigue; chills; fever; muscle aches; This is a spontaneous report from a contactable other health professional (patient). A 29-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), intramuscular (left arm) on 19Jan2021 17:30 at single dose for Covid-19 immunization. The patient's medical history was reported as none. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient experienced pain on arm of injection, fatigue, chills, fever, and muscle aches on 20Jan2021 (07:00 AM). There was no treatment received for the adverse events. The outcome of events was not recovered. The patient has not been tested for COVID-19 since the vaccination. This case is non-serious. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0993709
Sex: F
Age:
State: KY

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: broke out in hives on her face, arms, and chest; warm feeling; Itching; face was really swollen; face was really swollen and red; skin was blotchy; This is a spontaneous report from a contactable consumer reported for herself. A 64-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3248) at single dose via an unknown route at right arm on 16Jan2021 about 11:00 for vaccination against Covid. No additional vaccines administered on same date of the Pfizer Suspect. Medical history included anxiety, high blood pressure, and ongoing physical urticaria (with no investigation assessment) where if she gets warm her arms itch and she breaks out in a little bit of hives, but never to this extent. Concomitant drugs included lisinopril at 20mg, 1 tablet by mouth once daily for high blood pressure, and sertraline at 50mg, 1 tablet by mouth once daily for anxiety, both ongoing. History of all previous immunization with the Pfizer vaccine considered as suspect was reported as "none". No other vaccines given the same day and none 4 weeks prior. No history of problems with vaccines in past. Prior Vaccinations (within 4 weeks prior to the first administration date of the suspect vaccine was "none". No events following prior vaccinations. Family medical history relevant to the event was reported as "none". Patient reported an adverse event/side effect to the Covid vaccine, and was not sure if she should go ahead with the second dose or not. Patient received the vaccine on 16Jan2021 (reported as Saturday as of 18Jan2021) about 11am and at 5pm she started getting a warm feeling and changed to cooler clothing. Patient started itching and then broke out in hives on her face, arms, and chest. Patient used a cool cloth to face to cool off and sat under the fan. Her daughter got her some diphenhydramine hydrochloride (BENADRYL) within that 15minutes and about 20-30 minutes of taking the diphenhydramine hydrochloride it was calming down. Patient only took 1 diphenhydramine hydrochloride to help and that took care of it. This was the only occurrence. Her face was really swollen and red, she looked like she was sun burnt, skin was blotchy, but she didn't have any trouble with breathing or heart palpitations. The event onset date was 16Jan2021. The events did not require a visit to Emergency Room/ Physician Office. No relevant tests performed. Outcome of the events was resolving.

Other Meds: LISINOPRIL; SERTRALINE

Current Illness: Physical urticaria

ID: 0993710
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Name: Blood Type; Result Unstructured Data: Test Result:Type O Positive

Allergies:

Symptoms: headache; severe neck and shoulder pain; severe neck and shoulder pain; intense fatigue; arm was first very achy; shooting pain; redness; "hot" to touch; This is a spontaneous report from a contactable healthcare professional reporting for herself. A female patient of an unknown age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: not provided), via an unspecified route of administration, on an unknown date as a single dose for COVID-19 IMMUNIZATION. Relevant medical history and concomitant medication were not provided. The patient reported that her blood type was O positive. The patient previously received the first dose of BNT162B2 on an unknown date. On an unknown date, the first day after receiving the second dose of vaccination, the patient experienced headache, severe neck and shoulder pain, and intense fatigue like jetlag x10. On an unknown date, the patient experienced her arm was first very achy, then shooting pain, burning pain, and the past two days, redness, and very "hot" to touch. There was no cellulitis and no sign of infection. The patient was on day 4 and still experienced fatigue. The outcome of the other events headache, severe neck and shoulder pain, arm was achy, shooting pain, burning pain, redness, and "hot" to touch was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.

Other Meds:

Current Illness:

ID: 0993711
Sex: F
Age:
State: CA

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: chills with shaking; chills with shaking; joint pain; muscle pain; fatigue; swelling at injection site; pain at injection site; This is a spontaneous report from a contactable nurse (patient). A 44-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: EA9899, via an unspecified route of administration on Arm Left from 19Jan2021 08:15 to 19Jan2021 08:15 as single dose for COVID-19 immunisation. The patient took first dose of the BNT162B2 vaccine on an unspecified date. Medical history included asthma, penicillin (PCN) allergy, environmental allergies, and major depression. Concomitant medication included fluticasone propionate, salmeterol xinafoate (ADVAIR), montelukast sodium (SINGULAIR), fluoxetine hydrochloride (PROZAC), bupropion hydrochloride (WELLBUTRIN), and lamotrigine (LAMICTAL). On 19Jan2021 20:00, the patient experienced chills with shaking, joint pain, muscle pain, fatigue, swelling at injection site, and pain at injection site. The outcome of the events was recovering. Prior to vaccination and since the vaccination, was the patient was not diagnosed with COVID-19. No treatment was received for the events.

Other Meds: ADVAIR; SINGULAIR; PROZAC; WELLBUTRIN; LAMICTAL

Current Illness:

ID: 0993712
Sex: M
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: first injection caused arm and shoulder pain (in the arm that was injected) for about 2 days; first injection caused arm and shoulder pain (in the arm that was injected) for about 2 days; This is a spontaneous report from a contactable physician (patient himself). A male patient of an unspecified age received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot/batch number and expiry date were unknown), via an unspecified route of administration in the arm on unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient has received both of the Pfizer Covid19 vaccine doses, 3 weeks apart. He stated the first injection caused arm and shoulder pain (in the arm that was injected) for about 2 days. The outcome of the events was recovered on unspecified date. The second injection did not cause any adverse events. He felt fine and does not wish to be further contacted. No follow-up attempts are possible; information about the lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0993713
Sex: F
Age:
State: NY

Vax Date: 01/13/2021
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: soreness; fatigue; slight heaviness; This is a spontaneous report from a contactable other health professional. A 36-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, in the left arm, on 13Jan2021 17:15 at SINGLE DOSE for COVID-19 immunization. Medical history included Acid reflux. Patient received the first doe of BNT162B2 on 23Dec2021 for COVID-19 immunization There were no concomitant medications. On an unspecified date, the patient experienced soreness, fatigue and slight heaviness but still feel off today (16Jan2021). The outcome of events was recovering. Patient did not receive any treatment due to events. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0993714
Sex: F
Age:
State: NY

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Left hand got red and itchy; Left hand got red and itchy; This is a spontaneous report from a contactable healthcare professional (patient). An 84-year-old female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EL3247), via an unspecified route of administration in the left arm on 20Jan2021 10:00 at a single dose for covid-19 immunization. Medical history included allergies Penicillin and allergies: sulphur IV dye. Concomitant medication included omeprazole (PRILOSEC), levothyroxine sodium (SYNTHROID) and amlodipine besylate. The patient previously took augmentin [amoxicillin;clavulanic acid] and Sulphur where patient experienced allergies. On 20Jan2021 21:30, the patient experienced left hand got red and itchy. The patient was not diagnosed with covid-19 prior vaccination and has not been tested for covid-19 since the vaccination. The patient did not receive treatment for the event. The outcome of the events was not recovered.

Other Meds: PRILOSEC; SYNTHROID; AMLODIPINE BESYLATE

Current Illness:

ID: 0993715
Sex: F
Age:
State: CA

Vax Date: 01/10/2021
Onset Date: 01/10/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: the patient felt itchy; flushed; This is a spontaneous report from a contactable pharmacist. A 27-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), intramuscular in left arm on 10Jan2021 at single dose for COVID-19 immunization; and diphenhydramine hcl, via an unspecified route of administration from an unspecified date at unknown dose for premedication. Medical history was reported as none. The patient's concomitant medications were not reported. The patient previously had first dose of BNT162B2, lot number: EL0140, via intramuscular in left arm on 20Dec2020 at single dose for COVID-19 immunization and experienced itching. The patient was not pregnant. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient was pre-medicated with diphenhydramine prior to the second dose of the COVID-19 vaccine. 9 minutes after the vaccination on 10Jan2021, the patient felt itchy and flushed then received oral dexamethasone as treatment for the events. The patient was sent out with oral dexamethasone home. The outcome of the events was recovering. The action taken in response to diphenhydramine hcl for the events was unknown.

Other Meds:

Current Illness:

ID: 0993716
Sex: M
Age:
State: NJ

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210109; Test Name: Rapid test; Test Result: Negative

Allergies:

Symptoms: mild numbness of teeth and tongue; mild numbness of teeth and tongue; heaviness of head; I was very tired; arm pain lasted 2 days; This is a spontaneous report from a contactable Other HCP. This Other HCP reported himself that the 58-year-old male patient received second dose of bnt162b2 (COVID 19, Pfizer), via Intramuscular on 11Jan2021 10:00 AM on Left arm at single dose for covid-19 immunisation. Medical history included history of mitral valve repair and pacemaker. Known allergies was not known. Concomitant medications included Metoprolol 25 mg, Baby aspirin 81 mg, Antihistamine( Certizine hidrocloride 10mg,Costco brand). The patient previously took first dose of bnt162b2 (COVID 19, Pfizer), via Intramuscular on 21Dec2020 10:00 AM on Left arm at single dose for covid-19 immunisation. No other vaccine in four weeks. Side effect occurred after his 2nd dose (11Jan2021) he was feeling mild numbness of teeth and tongue heaviness of head after 30 minutes of vaccine. It lasted 5-6 hours, also he was very tired, and arm pain lasted 2 days. The events started from 11Jan2021 10:00 AM. The outcome of the events feeling mild numbness of teeth and tongue, heaviness of head was recovered on 11Jan2021. The outcome of the other event was recovered in Jan2021. No Covid prior vaccination. Covid tested post vaccination. covid test post vaccination included Rapid test on 09Jan2021 with covid test result: Negative. Information on the lot/batch number has been requested.

Other Meds: METOPROLOL; BABY ASPIRIN; CETRIZINE

Current Illness:

ID: 0993718
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Tired; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age (reported as 53; unit unknown) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced tired (reported as on the 1st shot) on an unspecified. The patient did not have did not have COVID prior to vaccination. The outcome of event was unknown. No follow-up attempts are possible. Information on lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0993719
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/02/2021
Hospital:

Lab Data:

Allergies:

Symptoms: shaking chills; fever; severe headache; body aches (muscle / joint); body aches (muscle / joint); nausea; reflux; This is a spontaneous report from a contactable other hcp. A 53-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown) , via an unspecified route of administration on an unspecified date at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced shaking chills, severe headache, body aches (muscle / joint), fever, nausea, reflux on an unspecified date. The patient did not have did not have COVID prior to vaccination. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0993720
Sex: F
Age:
State: MA

Vax Date: 01/17/2021
Onset Date: 01/17/2021
Rec V Date: 02/02/2021
Hospital:

Lab Data: Test Date: 20210117; Test Name: Low grade fever; Result Unstructured Data: Test Result:Lowgrade fever

Allergies:

Symptoms: sluggish and wanting to sleep all day; Sneezing; stuffy head; Low grade fever; Chills; bad headache; arm hurts; The initial case was missing the following minimum criteria- No Adverse Effect. Upon receipt of follow-up information on 19Jan2021, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: not provided - "has not received information card "), via an unspecified route of administration on 17Jan2021 at single dose on the left arm for COVID-19 immunization (reported as "Why was the patient taking Covid-19 vaccine (Verbatim): works in a group home "). Medical history included ongoing heart murmur since 2019. There were no concomitant medications. There were no investigation assessment. The patient experienced low-grade fever, chills and a bad headache on 17Jan2021. Patient was sluggish and wanting to sleep all day on 18Jan2021. Patient took Tylenol for a headache. It did not work so she took sumatriptan. The patient was also sneezing on 18Jan2021. Patient reported that she sweated the fever out. She had chills at night. The headache was lingering off and on but was mild. She sneezed all day on Monday (18Jan2021). She has not sneezed yet today but she has a stuffy head on 18Jan2021. Patient clarified that she took Acetaminophen Rapid Pain Relief instead of Tylenol. She took two 500mg tablets (UPC: 3225152303, Lot: 91670159AA, Expiry: Aug2022). Patient also reported that her arm hurts on 17Jan2021. She was unable to provide the Lot number. She will receive the information card after she receives the second dose. She had a picture of the card but it was not very clear. Outcome of the events arm hurts, headache, stuffy head was recovering (also reported as ongoing), for chills, low grade fever was recovered on 18Jan2021, for sluggish and wanting to sleep all day was recovered on 19Jan2021 while for other event was unknown. Information about batch/lot number has been requested.

Other Meds:

Current Illness: Heart murmur (Verbatim: Heart murmur)

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm